Evidence map›Paper›PMID 23049696›Full record

ArticlePloS one2012

VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity.

Meghana Rao, Wenqiang Song, Aixiang Jiang, Yu Shyr, Sima Lev, David Greenstein, Dana Brantley-Sieders, Jin Chen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Organelle contact sites in cancer cells.Cell death & disease · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lipid Transfer Proteins and Membrane Contact Sites in Human Cancer.Frontiers in cell and developmental biology · 2019
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Milk secretion: The role of SNARE proteins.Journal of mammary gland biology and neoplasia · 2014
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Meghana RaoDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Wenqiang Song
Aixiang Jiang
Yu Shyr
Sima Lev
David Greenstein
Dana Brantley-Sieders
Jin Chen
Vanderbilt University · USUniversity of Minnesota · USWeizmann Institute of Science · IL

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCERT32CA009592 · NCI · VANDERBILT UNIVERSITY · PI Justin M Balko, Julie A Rhoades (Sterling) · 1987 to 2026
$10.4M
CONTROL OF MEIOSIS AND GERMLINE PROLIFERATIONR01GM057173 · NIGMS · VANDERBILT UNIVERSITY · PI GREENSTEIN, DAVID IRWIN · 1998 to 2021
$6.6M
Ephrin-A1 in Tumor-Endothelial Interaction During MetastasisR01CA095004 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CHEN, JIN · 2003 to 2019
$4.6M
Control of Oocyte Maturation in C. elegansR01GM065115 · NIGMS · VANDERBILT UNIVERSITY · PI GREENSTEIN, DAVID IRWIN · 2002 to 2014
$3.7M
EphA2 Receptor Tyrosine Kinase in Malignant Tumor CellR01CA114301 · NCI · VANDERBILT UNIVERSITY · PI CHEN, JIN · 2005 to 2009
$1.5M
NCI NIH HHS KO1 CA1179151NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA095004NCI NIH HHS R01 CA114301NCI NIH HHS R01 CA95004NCI NIH HHS T32 CA009592NEI NIH HHS P30 EY008126NICHD NIH HHS P30 HD015052NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS U24 DK059637NIGMS NIH HHS R01 GM057173NIGMS NIH HHS R01 GM065115
6 · The paper itself

Abstract

VAPB (VAMP- associated protein B) is an ER protein that regulates multiple biological functions. Although aberrant expression of VAPB is associated with breast cancer, its function in tumor cells is poorly understood. In this report, we provide evidence that VAPB regulates breast tumor cell proliferation and AKT activation. VAPB protein expression is elevated in primary and metastatic tumor specimens, and VAPB mRNA expression levels correlated negatively with patient survival in two large breast tumor datasets. Overexpression of VAPB in mammary epithelial cells increased cell growth, whereas VAPB knockdown in tumor cells inhibited cell proliferation in vitro and suppressed tumor growth in orthotopic mammary gland allografts. The growth regulation of mammary tumor cells controlled by VAPB appears to be mediated, at least in part, by modulation of AKT activity. Overexpression of VAPB in MCF10A-HER2 cells enhances phosphorylation of AKT. In contrast, knockdown of VAPB in MMTV-Neu tumor cells inhibited pAKT levels. Pharmacological inhibition of AKT significantly reduced three-dimensional spheroid growth induced by VAPB. Collectively, the genetic, functional and mechanistic analyses suggest a role of VAPB in tumor promotion in human breast cancer.

Indexed as

Cell ProliferationAnalysis of VarianceAnimalsBreast NeoplasmsCell Line, TumorEnzyme ActivationFemaleGene Expression ProfilingHumansImmunoblottingImmunohistochemistryMiceMicroarray AnalysisOncogene Protein v-aktPhosphorylationPlasmidsOncogene Protein v-aktVAPB protein, humanVesicular Transport Proteins

Identifiers

PMID23049696
PMCPMC3462209
OpenAlexW2049568685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.